IGF1 and breast cancer: In a randomised controlled trial examining the effects of exercise in overweight or obese breast cancer survivors,38 circulating biomarkers (insulin, IGF‐1, adiponectin and leptin) were significantly improved post‐intervention, compared to usual care.